JAMA Internal Medicine
APRIL 30, 2020
This study delineates the transmission dynamics of coronavirus disease 2019 (COVID-19) and evaluates the transmission risk at different exposure window periods before and after symptom onset.
VirTrial
APRIL 29, 2020
The FDA recently released new guidance on clinical trials in the face of COVID-19. In their published report, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic , they acknowledged that challenges may arise in ongoing trials. For example, quarantines, site closures, travel limitations, etc. may lead to difficulties in meeting protocol-specified procedures including administering or using the investigational product or adhering to protocol-mandated visits and
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crucial Data Soutions
APRIL 27, 2020
The COVID-19 pandemic that struck the globe this year has drastically disrupted the state of affairs in the life sciences industry. Traditional methods of clinical data collection and trial management encountered change in mid-March as the FDA released guidance on conducting trials during the pandemic. In the guidance, the FDA emphasizes the importance of curtailing risk and further ensuring patient safety, and makes recommendations such as implementing a centralized or remote monitoring program
Drug Discovery Today
APRIL 28, 2020
Former J&J Senior Scientific Director and immunology expert joins at a pivotal time.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Find Me Cure
APRIL 30, 2020
Telehealth services have been around for a while now but it wasn’t until the Covid-19 epidemic that they became such a necessity. Although a lot of you express such bravery in the face of what is going on in the world, many are rightfully concerned for their health. . Especially if you are someone in the risk group – if you have an autoimmune disease, a respiratory disease, are over the age of 60, etc. – this is not the best time for you to visit the hospital.
pharmaphorum
APRIL 29, 2020
COVID-19 is making digital transformation even more pressing for pharmaceutical companies. Amid the coronavirus pandemic digital health offers many ways to develop public utility projects and enhance healthcare communications.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Discovery Today
MAY 1, 2020
Oxford BioDynamics’ EpiSwitch technology has been chosen as the biomarker platform for prognostic and predictive profiling of COVID-19 patients in the GETAFIX clinical study.Institute of Infection, Immunity and Inflammation, University of Glasgow, and NHS Scotland are leading the effort to identify patients at risk of severe immune complications and those patients who can benefit from treatment with the anti-viral favipiravir.The EpiSwitch platform has already delivered prognostic and predictive
JAMA Internal Medicine
APRIL 30, 2020
This randomized clinical trial examines the efficacy of gabapentin as pharmacotherapy for alchohol use disorder in adults with a history of alcohol withdrawal.
DM Clinical Research
APRIL 29, 2020
If you have COPD, then you might be worried about the coronavirus pandemic. While we all need to work to stay healthy, patients with lung disease need to be especially careful. Lung disease does not affect your chances of catching COVID-19. However, these diseases can make your symptoms worse if you do develop the coronavirus. Luckily, there are ways to manage your COPD.
ECRG Media's Clinical Research Podcast
APRIL 28, 2020
Getting Clinical Research Job During Covid 19 Pandemic Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Educati
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Discovery Today
APRIL 26, 2020
To mark the 30th Anniversary of World Haemophilia Day, Sobi have released the 2020 Haemophilia Index which examines the quality of life for people with haemophilia in Europe, including the UK and the reach of humanitarian aid across the globe.
Pharmacy Checkers
MAY 1, 2020
In late March, drug giant Bayer Pharmaceuticals, out of the goodness of its heart, agreed to donate three million tablets of chloroquine phosphate to help the Trump administration get this drug into U.S. pharmacies. That’s according to an investigative article in Vanity Fair by Katherine Eban, called: “‘ Really Want to Flood NY and NJ’: Internal Documents Reveal Team Trump’s Chloroquine Master Plan”.
Drug Discovery Today
APRIL 25, 2020
AUSTIN, Texas, April 23, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it is actively developing a COVID-19 triage test aiming to predict the likelihood that an individual who is COVID-19 positive will develop complications and severe disease, using its propriety Nu.QTM platform. The goal of the test is to provide early insight into which patients may require higher levels of monitoring including hospitalization and critical care resources, versu
Expert insights. Personalized for you.
111 
Let's personalize your content